Internal Medicine, Rheumatology · San Antonio, TX
NPI
1356432389
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4910 Golden Quail, Suite 180/190
San Antonio, TX, 78240
Phone (210) 690-9090
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
227,805 services
Medicare patients, 2024
427
Average age 72
Drug cost, 2024
$8.0M
5,339 prescriptions
Company payments, 2025
$1,462
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lama Hashish was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 156,400 times for 45 patients. In total Lama Hashish billed 227,805 services in 36 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 156,400 | 45 | $3.61 | $564K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 28,150 | 48 | $31.34 | $882K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 17,540 | 159 | $0.10 | $1,733 |
| J7329 Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 3,625 | 29 | $5.52 | $20K |
| J0897 Injection, denosumab, 1 mg | Office | 3,420 | 42 | $20.23 | $69K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 896 | 103 | $0.45 | $403 |
| 96401 Chemotherapy Administration | Office | 881 | 49 | $52.81 | $47K |
| 99214 Office E&M - Established | Office | 753 | 384 | $86.19 | $65K |
| 96372 Injection Administration | Office | 543 | 174 | $9.41 | $5,112 |
| 96413 Chemotherapy Administration | Office | 480 | 64 | $88.57 | $43K |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 459 | 60 | $1.90 | $874 |
| 20611 Joint Injection | Office | 222 | 79 | $89.22 | $20K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 195 | 39 | $4.88 | $952 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 80 | 66 | $5.72 | $458 |
| 99213 Office E&M - Established | Office | 67 | 58 | $63.71 | $4,268 |
By year: 2022 $1.6M for 164,581 services; 2023 $1.9M for 181,167 services; 2024 $1.8M for 227,805 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lama Hashish prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 909 prescriptions and refills. In total Lama Hashish wrote 5,339 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 909 | 1,367 | 207 | $16K |
| Gabapentin Generic | 665 | 1,201 | 184 | $13K |
| Hydroxychloroquine Sulfate Generic | 413 | 800 | 94 | $13K |
| Pregabalin Generic | 287 | 291 | 38 | $6,188 |
| Prednisone Generic | 252 | 319 | 103 | $938 |
| Enbrel Sureclick Etanercept | 195 | 201 | 31 | $1.5M |
| Alendronate Sodium Generic | 135 | 262 | 38 | $605 |
| Folic Acid Generic | 135 | 235 | 38 | $725 |
| Humira(Cf) Pen Adalimumab | 134 | 139 | 25 | $1.5M |
| Risedronate Sodium Generic | 133 | 215 | 34 | $6,644 |
| Tramadol Hcl Generic | 129 | 129 | 24 | $562 |
| Cevimeline Hcl Generic | 106 | 152 | 26 | $15K |
| Leflunomide Generic | 98 | 140 | 20 | $3,092 |
| Orencia Abatacept/Maltose | 92 | 92 | 14 | $404K |
| Methotrexate Sodium Methotrexate Sodium/Pf | 84 | 105 | 28 | $844 |
Brand drugs: 1,233 claims; generic drugs: 4,079 claims; opioid claims: 155.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lama Hashish $1,462 ($1,462 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $279.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $279 |
| UCB, Inc. UCB.BR | 6 | $191 |
| Amgen Inc. AMGN | 6 | $146 |
| Janssen Biotech, Inc. JNJ | 3 | $144 |
| Argenx US, Inc. ARGX | 1 | $137 |
| GlaxoSmithKline, LLC. GSK | 2 | $124 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $82.06 |
| Mallinckrodt Hospital Products Inc. | 3 | $77.18 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $76.7 |
| Fidia Pharma USA Inc. | 2 | $41.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.